Daiichi Sankyo Europe GmbH is a pharmaceutical company with a strong focus on innovation and compassion for patients. The company is dedicated to providing innovative pharmaceutical therapies to address unmet medical needs and improve standards of care globally. In Europe, the company aims to be a benchmark for customer centricity and a competitive player in the Oncology sector. With operations in 13 countries, Daiichi Sankyo Europe emphasizes the significant impact each employee can have, encouraging them to challenge conventional thinking and share their local recipes for success and learnings with the whole company. The company culture values courage, passion, and the willingness to go beyond regular duties to achieve results. As an investor, the company's commitment to leveraging its world-class science and technology to make a difference in the pharmaceutical industry is notable. The dedication to addressing unmet medical needs and fostering a culture of collaboration and innovation positions Daiichi Sankyo Europe as a potential investment opportunity in the health care sector. With a strong focus on talent acquisition and continuous improvement, the company presents promising potential for sustainable growth and success in the industry. For more information, please visit www.daiichi-sankyo.eu/imprint.
There is no investment information
No recent news or press coverage available for Daiichi Sankyo Europe GmbH.